Fig. 1From: Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomasKaplan-Meier survival curves of PFS (a) and OS (b) from start of BEV treatment of the patients analysed in the studyBack to article page